Allelic losses associated with the metastatic potential of colorectal carcinoma

G. Ishimaru, K. Ookawa, N. Yamaguchi, Michiie Sakamoto, S. Hirohashi, T. Muto, J. Yokota

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The aim of this study was to define the association of allelic losses with the metastatic potential of colorectal carcinoma and to determine whether allelic losses can be genetic markers for the prognosis of patients with colorectal carcinoma. Eighty primary colorectal tumors and 31 liver metastases from 95 patients were examined for loss of heterozygosity (LOH) at the APC, p53, RB, DCC and chromosome 14q loci by using polymerase chain reaction-single strand conformation polymorphism analysis and restriction fragment length polymorphism analysis. The incidence of LOH at the DCC and RB loci and on chromosome 14q in liver metastases was significantly higher than that in primary tumors. DCC and RB alterations were detected more frequently in primary tumors with higher metastatic potential. Although no statistically significant association was found between these losses and survival or distant metastasis, patients with DCC losses showed poorer survival by multivariate analysis (p = 0.056). Thus, inactivation of the DCC and RB genes and gene(s) on chromosome 14q seem to be critical genetic events for the acquisition of metastatic potential in colorectal carcinoma. However, further studies will be required to utilize these genetic alterations as valuable prognostic markers.

Original languageEnglish
Pages (from-to)267-273
Number of pages7
JournalInternational Journal of Oncology
Volume5
Issue number2
Publication statusPublished - 1994
Externally publishedYes

Fingerprint

Loss of Heterozygosity
Colorectal Neoplasms
Chromosomes
Neoplasm Metastasis
DCC Genes
Liver
Survival Analysis
Genetic Markers
Restriction Fragment Length Polymorphisms
Neoplasms
Multivariate Analysis
Polymerase Chain Reaction
Survival
Incidence
Genes

Keywords

  • Colorectal carcinoma
  • Loss of heterozygosity
  • Metastasis
  • Prognosis
  • Tumor suppressor gene

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ishimaru, G., Ookawa, K., Yamaguchi, N., Sakamoto, M., Hirohashi, S., Muto, T., & Yokota, J. (1994). Allelic losses associated with the metastatic potential of colorectal carcinoma. International Journal of Oncology, 5(2), 267-273.

Allelic losses associated with the metastatic potential of colorectal carcinoma. / Ishimaru, G.; Ookawa, K.; Yamaguchi, N.; Sakamoto, Michiie; Hirohashi, S.; Muto, T.; Yokota, J.

In: International Journal of Oncology, Vol. 5, No. 2, 1994, p. 267-273.

Research output: Contribution to journalArticle

Ishimaru, G, Ookawa, K, Yamaguchi, N, Sakamoto, M, Hirohashi, S, Muto, T & Yokota, J 1994, 'Allelic losses associated with the metastatic potential of colorectal carcinoma', International Journal of Oncology, vol. 5, no. 2, pp. 267-273.
Ishimaru G, Ookawa K, Yamaguchi N, Sakamoto M, Hirohashi S, Muto T et al. Allelic losses associated with the metastatic potential of colorectal carcinoma. International Journal of Oncology. 1994;5(2):267-273.
Ishimaru, G. ; Ookawa, K. ; Yamaguchi, N. ; Sakamoto, Michiie ; Hirohashi, S. ; Muto, T. ; Yokota, J. / Allelic losses associated with the metastatic potential of colorectal carcinoma. In: International Journal of Oncology. 1994 ; Vol. 5, No. 2. pp. 267-273.
@article{992f142008124ef0bb8f139184d2e5a8,
title = "Allelic losses associated with the metastatic potential of colorectal carcinoma",
abstract = "The aim of this study was to define the association of allelic losses with the metastatic potential of colorectal carcinoma and to determine whether allelic losses can be genetic markers for the prognosis of patients with colorectal carcinoma. Eighty primary colorectal tumors and 31 liver metastases from 95 patients were examined for loss of heterozygosity (LOH) at the APC, p53, RB, DCC and chromosome 14q loci by using polymerase chain reaction-single strand conformation polymorphism analysis and restriction fragment length polymorphism analysis. The incidence of LOH at the DCC and RB loci and on chromosome 14q in liver metastases was significantly higher than that in primary tumors. DCC and RB alterations were detected more frequently in primary tumors with higher metastatic potential. Although no statistically significant association was found between these losses and survival or distant metastasis, patients with DCC losses showed poorer survival by multivariate analysis (p = 0.056). Thus, inactivation of the DCC and RB genes and gene(s) on chromosome 14q seem to be critical genetic events for the acquisition of metastatic potential in colorectal carcinoma. However, further studies will be required to utilize these genetic alterations as valuable prognostic markers.",
keywords = "Colorectal carcinoma, Loss of heterozygosity, Metastasis, Prognosis, Tumor suppressor gene",
author = "G. Ishimaru and K. Ookawa and N. Yamaguchi and Michiie Sakamoto and S. Hirohashi and T. Muto and J. Yokota",
year = "1994",
language = "English",
volume = "5",
pages = "267--273",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "2",

}

TY - JOUR

T1 - Allelic losses associated with the metastatic potential of colorectal carcinoma

AU - Ishimaru, G.

AU - Ookawa, K.

AU - Yamaguchi, N.

AU - Sakamoto, Michiie

AU - Hirohashi, S.

AU - Muto, T.

AU - Yokota, J.

PY - 1994

Y1 - 1994

N2 - The aim of this study was to define the association of allelic losses with the metastatic potential of colorectal carcinoma and to determine whether allelic losses can be genetic markers for the prognosis of patients with colorectal carcinoma. Eighty primary colorectal tumors and 31 liver metastases from 95 patients were examined for loss of heterozygosity (LOH) at the APC, p53, RB, DCC and chromosome 14q loci by using polymerase chain reaction-single strand conformation polymorphism analysis and restriction fragment length polymorphism analysis. The incidence of LOH at the DCC and RB loci and on chromosome 14q in liver metastases was significantly higher than that in primary tumors. DCC and RB alterations were detected more frequently in primary tumors with higher metastatic potential. Although no statistically significant association was found between these losses and survival or distant metastasis, patients with DCC losses showed poorer survival by multivariate analysis (p = 0.056). Thus, inactivation of the DCC and RB genes and gene(s) on chromosome 14q seem to be critical genetic events for the acquisition of metastatic potential in colorectal carcinoma. However, further studies will be required to utilize these genetic alterations as valuable prognostic markers.

AB - The aim of this study was to define the association of allelic losses with the metastatic potential of colorectal carcinoma and to determine whether allelic losses can be genetic markers for the prognosis of patients with colorectal carcinoma. Eighty primary colorectal tumors and 31 liver metastases from 95 patients were examined for loss of heterozygosity (LOH) at the APC, p53, RB, DCC and chromosome 14q loci by using polymerase chain reaction-single strand conformation polymorphism analysis and restriction fragment length polymorphism analysis. The incidence of LOH at the DCC and RB loci and on chromosome 14q in liver metastases was significantly higher than that in primary tumors. DCC and RB alterations were detected more frequently in primary tumors with higher metastatic potential. Although no statistically significant association was found between these losses and survival or distant metastasis, patients with DCC losses showed poorer survival by multivariate analysis (p = 0.056). Thus, inactivation of the DCC and RB genes and gene(s) on chromosome 14q seem to be critical genetic events for the acquisition of metastatic potential in colorectal carcinoma. However, further studies will be required to utilize these genetic alterations as valuable prognostic markers.

KW - Colorectal carcinoma

KW - Loss of heterozygosity

KW - Metastasis

KW - Prognosis

KW - Tumor suppressor gene

UR - http://www.scopus.com/inward/record.url?scp=0028048201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028048201&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0028048201

VL - 5

SP - 267

EP - 273

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 2

ER -